These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
538 related articles for article (PubMed ID: 33244856)
1. Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments. Boban M Int J Clin Pract; 2021 Apr; 75(4):e13868. PubMed ID: 33244856 [TBL] [Abstract][Full Text] [Related]
2. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308 [TBL] [Abstract][Full Text] [Related]
3. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927 [TBL] [Abstract][Full Text] [Related]
4. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428 [TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus. Costanzo M; De Giglio MAR; Roviello GN Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571 [TBL] [Abstract][Full Text] [Related]
7. Psychopharmacology of COVID-19. Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246 [TBL] [Abstract][Full Text] [Related]
8. Case Report of Patients with Acute Respiratory Distress Syndrome Caused by COVID-19: Successfully Treated by Venovenous Extracorporeal Membrane Oxygenation and an Ultra-Protective Ventilation. Park MH; Kim AJ; Lee MJ; Kim YS; Kim JS Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33137936 [TBL] [Abstract][Full Text] [Related]
9. Consensus statement and recommendations on the treatment of COVID-19: 2021 update. Ko HK; Yu WK; Pan SW; Chen WC; Yang KY; Lin YT; Wang FD; Yang MH; Chen YM; J Chin Med Assoc; 2022 Jan; 85(1):5-17. PubMed ID: 34524227 [TBL] [Abstract][Full Text] [Related]
10. Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks. Wooding DJ; Bach H Clin Microbiol Infect; 2020 Oct; 26(10):1436-1446. PubMed ID: 32791241 [TBL] [Abstract][Full Text] [Related]
11. [The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]. Cruciani F; Amato L; De Crescenzo F; Mitrova Z; Saulle R; Vecchi S; Davoli M Recenti Prog Med; 2021 Mar; 112(3):195-206. PubMed ID: 33687358 [TBL] [Abstract][Full Text] [Related]
12. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021). Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123 [TBL] [Abstract][Full Text] [Related]
13. Perspectives on the Early Quality of Evidence Guiding the Therapeutic Management of SARS-CoV-2: A Systematic Literature Review. Subramanian K; Nalli A; Senthil V; Jain S; Nayak A; Bhat A Adv Ther; 2020 Oct; 37(10):4107-4131. PubMed ID: 32809210 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic options in the treatment of severe acute respiratory syndrome coronavirus 2 in pregnant patient. Lat TI; Patel CD; Ehrig JC; Moslander C; Sanchez JF Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100224. PubMed ID: 32954247 [TBL] [Abstract][Full Text] [Related]
15. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19. Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696 [TBL] [Abstract][Full Text] [Related]
17. The Perspective of Coronavirus Disease Outbreak: Epidemiology, Transmission, and Possible Treatment. Naik AQ; Zafar T; Shrivastava VK Vector Borne Zoonotic Dis; 2021 Feb; 21(2):78-85. PubMed ID: 33325821 [TBL] [Abstract][Full Text] [Related]
18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849 [TBL] [Abstract][Full Text] [Related]
20. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]